Published • loading... • Updated
Biodesix expects 2026 sales to crack $100M
Summary by Daily Camera
1 Articles
1 Articles
Biodesix expects 2026 sales to crack $100M
LOUISVILLE — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, improved its top and bottom lines in both the fourth quarter of last year and the full 2025 fiscal year. The company posted total sales of $28.8 million in the most-recent period, good for a 41% year-over-year bump, and $88.5 million in fiscal 2025, an increase of 24%. Biodesix’s net loss in the fourth quarter was $4 mi…
·Boulder, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
